dichlorotetrakis(dimethyl sulfoxide)ruthenium ii profile

dichlorotetrakis(dimethyl sulfoxide)ruthenium II: RN given refers to parent cpd without isomeric designation, [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

ID Source	ID
PubMed CID	150194
MeSH ID	M0116445

Synonym
dichlorotetrakis(dimethyl sulfoxide)ruthenium(ii)
ruthenium, dichlorotetrakis(methylsulfoxide)-
nsc 637822
dichlorotetrakis(sulfinylbis(methane))ruthenium
tetrakis(dimethyl sulfoxide)ruthenium(2+) dichloride
dichlorotetrakis(methylsulfoxide)ruthenium
ruthenium, dichlorotetrakis(sulfinylbis(methane))-
dichlorotetrakis(dimethyl sulfoxide)ruthenium ii
ruthenium, dichloro(sulfinylbis(methane)-o)tris(sulfinylbis(methane)-s)-, (oc-6-22)-
dichlorotetrakis(dimethylsulfoxide)ruthenium(ii)
nsc637822
11070-19-2
tetrakis(dimethylsulfoxide)dichlororuthenium (ii)
dichlororuthenium; methylsulfinylmethane
89395-66-4
tetrakis(dimethylsulfoxide)dichlororuthenium(ii)
DTXSID20149364
mfcd00050955
rucl2(dmso)4
cis-tetrakis(dimethylsulfoxide)dichlororuthenium(ii)
UMJDEUKQHKMAOI-UHFFFAOYSA-L
dichlororuthenium;methylsulfinylmethane

Timeframe	Studies, This Drug (%)	All Drugs %
pre-1990	2 (16.67)	18.7374
1990's	4 (33.33)	18.2507
2000's	4 (33.33)	29.6817
2010's	1 (8.33)	24.3611
2020's	1 (8.33)	2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Publication Type	This drug (%)	All Drugs (%)
Trials	0 (0.00%)	5.53%
Reviews	1 (7.14%)	6.00%
Case Studies	0 (0.00%)	4.05%
Observational	0 (0.00%)	0.25%
Other	13 (92.86%)	84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Substance	Relationship Strength	Studies	Classes	Roles
dimethyl sulfoxide Dimethyl Sulfoxide: A highly polar organic liquid, that is used widely as a chemical solvent. Because of its ability to penetrate biological membranes, it is used as a vehicle for topical application of pharmaceuticals. It is also used to protect tissue during CRYOPRESERVATION. Dimethyl sulfoxide shows a range of pharmacological activity including analgesia and anti-inflammation.. dimethyl sulfoxide : A 2-carbon sulfoxide in which the sulfur atom has two methyl substituents.	2.41	2	sulfoxide; volatile organic compound	alkylating agent; antidote; Escherichia coli metabolite; geroprotector; MRI contrast agent; non-narcotic analgesic; polar aprotic solvent; radical scavenger
acetonitrile acetonitrile: RN given refers to unlabeled cpd. acetonitrile : A nitrile that is hydrogen cyanide in which the hydrogen has been replaced by a methyl group.	2.02	1	aliphatic nitrile; volatile organic compound	EC 3.5.1.4 (amidase) inhibitor; NMR chemical shift reference compound; polar aprotic solvent
indazoles Indazoles: A group of heterocyclic aromatic organic compounds consisting of the fusion of BENZENE and PYRAZOLES.	2.02	1	indazole
iridium Iridium: A metallic element with the atomic symbol Ir, atomic number 77, and atomic weight 192.22.	1.96	1	cobalt group element atom; platinum group metal atom
rhodium Rhodium: A hard and rare metal of the platinum group, atomic number 45, atomic weight 102.905, symbol Rh.. rhodium atom : A cobalt group element atom of atomic number 45.	1.96	1	cobalt group element atom
ruthenium Ruthenium: A hard, brittle, grayish-white rare earth metal with an atomic symbol Ru, atomic number 44, and atomic weight 101.07. It is used as a catalyst and hardener for PLATINUM and PALLADIUM.	3.08	5	iron group element atom; platinum group metal atom
oligonucleotides [no description available]	2	1
ascorbic acid Ascorbic Acid: A six carbon compound related to glucose. It is found naturally in citrus fruits and many vegetables. Ascorbic acid is an essential nutrient in human diets, and necessary to maintain connective tissue and bone. Its biologically active form, vitamin C, functions as a reducing agent and coenzyme in several metabolic pathways. Vitamin C is considered an antioxidant.. L-ascorbic acid : The L-enantiomer of ascorbic acid and conjugate acid of L-ascorbate.. L-ascorbate : The L-enantiomer of ascorbate and conjugate base of L-ascorbic acid, arising from selective deprotonation of the 3-hydroxy group. Required for a range of essential metabolic reactions in all animals and plants.. vitamin C : Any member of a group of vitamers that belong to the chemical structural class called butenolides that exhibit biological activity against vitamin C deficiency in animals. The vitamers include L-ascorbic acid and its salt, ionized and oxidized forms.	2.03	1	ascorbic acid; vitamin C	coenzyme; cofactor; flour treatment agent; food antioxidant; food colour retention agent; geroprotector; plant metabolite; skin lightening agent
deoxyguanosine [no description available]	2.39	2	purine 2'-deoxyribonucleoside; purines 2'-deoxy-D-ribonucleoside	Escherichia coli metabolite; human metabolite; mouse metabolite; Saccharomyces cerevisiae metabolite
deoxyadenylyl-(3'-5')-deoxyguanosine [no description available]	2	1
deoxyguanylyl-(3'-5')-guanosine deoxyguanylyl-(3'-5')-guanosine: RN given refers to parent cpd	2.39	2

Condition	Relationship Strength	Studies
Carcinoma, Non-Small Cell Lung [description not available]	2.07	1
Cancer of Lung [description not available]	2.67	3
Carcinoma, Non-Small-Cell Lung A heterogeneous aggregate of at least three distinct histological types of lung cancer, including SQUAMOUS CELL CARCINOMA; ADENOCARCINOMA; and LARGE CELL CARCINOMA. They are dealt with collectively because of their shared treatment strategy.	2.07	1
Lung Neoplasms Tumors or cancer of the LUNG.	2.67	3
Metastase [description not available]	2.42	2
Neoplasm Metastasis The transfer of a neoplasm from one organ or part of the body to another remote from the primary site.	2.42	2
Malignant Melanoma [description not available]	1.96	1
Experimental Neoplasms [description not available]	2.37	2
Experimental Mammary Neoplasms [description not available]	1.96	1
Melanoma A malignant neoplasm derived from cells that are capable of forming melanin, which may occur in the skin of any part of the body, in the eye, or, rarely, in the mucous membranes of the genitalia, anus, oral cavity, or other sites. It occurs mostly in adults and may originate de novo or from a pigmented nevus or malignant lentigo. Melanomas frequently metastasize widely, and the regional lymph nodes, liver, lungs, and brain are likely to be involved. The incidence of malignant skin melanomas is rising rapidly in all parts of the world. (Stedman, 25th ed; from Rook et al., Textbook of Dermatology, 4th ed, p2445)	1.96	1
Benign Neoplasms, Brain [description not available]	1.98	1
Leukemia P388 An experimental lymphocytic leukemia originally induced in DBA/2 mice by painting with methylcholanthrene.	1.98	1
Brain Neoplasms Neoplasms of the intracranial components of the central nervous system, including the cerebral hemispheres, basal ganglia, hypothalamus, thalamus, brain stem, and cerebellum. Brain neoplasms are subdivided into primary (originating from brain tissue) and secondary (i.e., metastatic) forms. Primary neoplasms are subdivided into benign and malignant forms. In general, brain tumors may also be classified by age of onset, histologic type, or presenting location in the brain.	1.98	1
Adenocarcinoma, Basal Cell [description not available]	2	1
Adenocarcinoma A malignant epithelial tumor with a glandular organization.	2	1
Invasiveness, Neoplasm [description not available]	2	1

dichlorotetrakis(dimethyl sulfoxide)ruthenium ii

Description

Cross-References

Synonyms (22)

Research

Studies (12)

Market Indicators

Research Demand Index: 17.35

Study Types

dichlorotetrakis(dimethyl sulfoxide)ruthenium ii

Description

Cross-References

Synonyms (22)

Research

Studies (12)

Market Indicators

Research Demand Index: 17.35

Study Types

Related Drugs (11)

Related Conditions (16)